 Valerie Minarchick
Concepts (152)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanoparticles | 6 | 2019 | 325 | 1.160 |
Why?
| | Cerium | 2 | 2014 | 12 | 1.000 |
Why?
| | Vasodilation | 3 | 2014 | 457 | 0.800 |
Why?
| | Arterioles | 3 | 2014 | 46 | 0.660 |
Why?
| | Coronary Vessels | 3 | 2015 | 233 | 0.540 |
Why?
| | Mesentery | 1 | 2014 | 56 | 0.500 |
Why?
| | Mesenteric Arteries | 1 | 2013 | 16 | 0.480 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2014 | 236 | 0.440 |
Why?
| | Titanium | 4 | 2019 | 67 | 0.440 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2014 | 454 | 0.430 |
Why?
| | Extracellular Traps | 2 | 2023 | 40 | 0.430 |
Why?
| | Particulate Matter | 3 | 2015 | 244 | 0.300 |
Why?
| | Lung | 3 | 2019 | 3664 | 0.280 |
Why?
| | Rats, Sprague-Dawley | 7 | 2015 | 2478 | 0.270 |
Why?
| | Reactive Oxygen Species | 5 | 2019 | 576 | 0.240 |
Why?
| | Microcirculation | 3 | 2013 | 155 | 0.230 |
Why?
| | Antiphospholipid Syndrome | 1 | 2023 | 29 | 0.230 |
Why?
| | Signal Transduction | 2 | 2019 | 4709 | 0.220 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2014 | 1945 | 0.200 |
Why?
| | Anti-Citrullinated Protein Antibodies | 1 | 2021 | 89 | 0.190 |
Why?
| | Environmental Exposure | 3 | 2019 | 405 | 0.190 |
Why?
| | Granulocyte Precursor Cells | 1 | 2019 | 7 | 0.180 |
Why?
| | Zinc Oxide | 1 | 2019 | 10 | 0.180 |
Why?
| | Sputum | 1 | 2021 | 290 | 0.180 |
Why?
| | Silver | 1 | 2019 | 27 | 0.180 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2019 | 97 | 0.170 |
Why?
| | Metal Nanoparticles | 1 | 2019 | 73 | 0.170 |
Why?
| | Toxicity Tests | 2 | 2019 | 26 | 0.160 |
Why?
| | Neutrophils | 2 | 2023 | 1233 | 0.160 |
Why?
| | Particle Size | 2 | 2019 | 345 | 0.160 |
Why?
| | Animals | 14 | 2023 | 33381 | 0.140 |
Why?
| | Administration, Inhalation | 2 | 2014 | 656 | 0.140 |
Why?
| | Air Pollutants, Occupational | 1 | 2015 | 33 | 0.130 |
Why?
| | Chromium | 1 | 2015 | 12 | 0.130 |
Why?
| | Rats | 8 | 2015 | 5392 | 0.130 |
Why?
| | Soluble Guanylyl Cyclase | 1 | 2014 | 15 | 0.130 |
Why?
| | Cadmium | 1 | 2015 | 62 | 0.130 |
Why?
| | Mitochondrial Diseases | 1 | 2015 | 79 | 0.130 |
Why?
| | Guanylate Cyclase | 1 | 2014 | 36 | 0.130 |
Why?
| | Microvessels | 1 | 2015 | 77 | 0.130 |
Why?
| | Cyclic GMP | 1 | 2014 | 109 | 0.130 |
Why?
| | Injections, Intravenous | 1 | 2014 | 210 | 0.120 |
Why?
| | Intubation, Gastrointestinal | 1 | 2014 | 61 | 0.120 |
Why?
| | Endothelial Cells | 1 | 2019 | 732 | 0.120 |
Why?
| | Organ Culture Techniques | 1 | 2013 | 149 | 0.120 |
Why?
| | Arthritis, Rheumatoid | 1 | 2021 | 989 | 0.110 |
Why?
| | Trachea | 1 | 2015 | 226 | 0.110 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 195 | 0.110 |
Why?
| | Coal Mining | 1 | 2013 | 9 | 0.110 |
Why?
| | Mitochondria | 2 | 2015 | 786 | 0.110 |
Why?
| | Air Pollution | 1 | 2015 | 209 | 0.110 |
Why?
| | Busulfan | 1 | 2012 | 14 | 0.110 |
Why?
| | Macrophages | 1 | 2019 | 1324 | 0.110 |
Why?
| | Nanotubes, Carbon | 1 | 2012 | 44 | 0.110 |
Why?
| | Administration, Oral | 1 | 2014 | 756 | 0.110 |
Why?
| | Vasoconstriction | 1 | 2013 | 213 | 0.110 |
Why?
| | Alanine | 1 | 2012 | 102 | 0.110 |
Why?
| | Heart Diseases | 1 | 2015 | 341 | 0.110 |
Why?
| | Pneumonia | 2 | 2015 | 592 | 0.110 |
Why?
| | Nanostructures | 1 | 2013 | 100 | 0.110 |
Why?
| | Xenobiotics | 1 | 2012 | 25 | 0.100 |
Why?
| | Endothelium, Vascular | 3 | 2013 | 907 | 0.100 |
Why?
| | Hydroxyl Radical | 1 | 2012 | 94 | 0.100 |
Why?
| | Maternal Exposure | 1 | 2013 | 142 | 0.100 |
Why?
| | Glutathione | 1 | 2012 | 324 | 0.100 |
Why?
| | Vascular Diseases | 1 | 2013 | 241 | 0.090 |
Why?
| | Gene Expression | 1 | 2015 | 1489 | 0.090 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2015 | 468 | 0.090 |
Why?
| | Liver | 2 | 2015 | 1816 | 0.090 |
Why?
| | Nitric Oxide | 1 | 2014 | 892 | 0.090 |
Why?
| | Air Pollutants | 1 | 2013 | 316 | 0.080 |
Why?
| | Fetus | 1 | 2013 | 690 | 0.080 |
Why?
| | Epithelial Cells | 1 | 2014 | 963 | 0.080 |
Why?
| | Male | 9 | 2021 | 57801 | 0.080 |
Why?
| | Oxidative Stress | 3 | 2019 | 1178 | 0.080 |
Why?
| | Apoptosis | 3 | 2019 | 2484 | 0.060 |
Why?
| | Adenylate Kinase | 1 | 2023 | 29 | 0.060 |
Why?
| | Interleukin-6 | 2 | 2019 | 688 | 0.060 |
Why?
| | Mice | 4 | 2023 | 15520 | 0.060 |
Why?
| | Hydrogen Peroxide | 2 | 2015 | 305 | 0.050 |
Why?
| | Cardiovascular Diseases | 1 | 2012 | 1798 | 0.050 |
Why?
| | Cell Degranulation | 1 | 2019 | 38 | 0.050 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2019 | 56 | 0.050 |
Why?
| | RAW 264.7 Cells | 1 | 2019 | 42 | 0.050 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2019 | 112 | 0.040 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2019 | 204 | 0.040 |
Why?
| | Solubility | 1 | 2019 | 235 | 0.040 |
Why?
| | Surface Properties | 1 | 2019 | 397 | 0.040 |
Why?
| | Respiratory Function Tests | 1 | 2019 | 526 | 0.040 |
Why?
| | Phagocytosis | 1 | 2019 | 364 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2019 | 331 | 0.040 |
Why?
| | Cell Survival | 1 | 2019 | 1047 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2019 | 870 | 0.030 |
Why?
| | In Situ Nick-End Labeling | 1 | 2015 | 124 | 0.030 |
Why?
| | Injections, Spinal | 1 | 2015 | 105 | 0.030 |
Why?
| | Cell Respiration | 1 | 2015 | 76 | 0.030 |
Why?
| | Tungsten Compounds | 1 | 2015 | 4 | 0.030 |
Why?
| | Toxicity Tests, Acute | 1 | 2015 | 10 | 0.030 |
Why?
| | Cobalt | 1 | 2015 | 48 | 0.030 |
Why?
| | Bronchoalveolar Lavage | 1 | 2015 | 89 | 0.030 |
Why?
| | Uterine Artery | 1 | 2015 | 65 | 0.030 |
Why?
| | Humans | 5 | 2023 | 118974 | 0.030 |
Why?
| | Mechanotransduction, Cellular | 1 | 2015 | 101 | 0.030 |
Why?
| | Caspases | 1 | 2015 | 269 | 0.030 |
Why?
| | Myocardial Contraction | 1 | 2015 | 339 | 0.030 |
Why?
| | Cell Line | 1 | 2019 | 2707 | 0.030 |
Why?
| | Environmental Monitoring | 1 | 2015 | 296 | 0.030 |
Why?
| | Uterine Contraction | 1 | 2013 | 16 | 0.030 |
Why?
| | Splanchnic Circulation | 1 | 2013 | 12 | 0.030 |
Why?
| | Appalachian Region | 1 | 2013 | 17 | 0.030 |
Why?
| | Echocardiography | 1 | 2015 | 556 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 2015 | 586 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2012 | 56 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2015 | 770 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1597 | 0.030 |
Why?
| | Coronary Circulation | 1 | 2013 | 121 | 0.030 |
Why?
| | Phenylephrine | 1 | 2012 | 85 | 0.030 |
Why?
| | Nitroprusside | 1 | 2012 | 88 | 0.030 |
Why?
| | DNA Damage | 1 | 2015 | 357 | 0.030 |
Why?
| | Inhalation Exposure | 1 | 2013 | 87 | 0.030 |
Why?
| | Cyclic N-Oxides | 1 | 2012 | 31 | 0.030 |
Why?
| | Pregnancy | 2 | 2015 | 5691 | 0.030 |
Why?
| | Biocatalysis | 1 | 2012 | 64 | 0.030 |
Why?
| | Glutathione Transferase | 1 | 2012 | 97 | 0.030 |
Why?
| | Electron Spin Resonance Spectroscopy | 1 | 2012 | 83 | 0.030 |
Why?
| | Metals | 1 | 2013 | 111 | 0.030 |
Why?
| | Arterial Pressure | 1 | 2012 | 99 | 0.030 |
Why?
| | Acetylcholine | 1 | 2012 | 208 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2015 | 477 | 0.030 |
Why?
| | Uterus | 1 | 2013 | 194 | 0.030 |
Why?
| | Microscopy | 1 | 2013 | 125 | 0.030 |
Why?
| | Cytokines | 1 | 2019 | 1900 | 0.030 |
Why?
| | Aerosols | 1 | 2013 | 221 | 0.030 |
Why?
| | Organ Size | 1 | 2012 | 460 | 0.030 |
Why?
| | Chromatography, Liquid | 1 | 2012 | 355 | 0.020 |
Why?
| | Iron | 1 | 2012 | 248 | 0.020 |
Why?
| | Fetal Development | 1 | 2013 | 250 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2012 | 613 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2012 | 421 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2015 | 1171 | 0.020 |
Why?
| | Biomarkers | 1 | 2019 | 3588 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2012 | 940 | 0.020 |
Why?
| | Pyridines | 1 | 2012 | 440 | 0.020 |
Why?
| | Kinetics | 1 | 2012 | 1624 | 0.020 |
Why?
| | Heart | 1 | 2012 | 631 | 0.020 |
Why?
| | Antioxidants | 1 | 2012 | 564 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 9000 | 0.020 |
Why?
| | Myocardium | 1 | 2012 | 970 | 0.020 |
Why?
| | Female | 3 | 2021 | 61565 | 0.020 |
Why?
| | Kidney | 1 | 2012 | 1353 | 0.020 |
Why?
| | Inflammation | 1 | 2015 | 2566 | 0.020 |
Why?
| | Time Factors | 1 | 2012 | 6412 | 0.010 |
Why?
|
|
Minarchick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|